SensoDetect offers, with the product SensoDetect® BERA, objective decision support for psychiatric diagnostics, currently with high sensitivity for indicating schizophrenia and ADHD. The underlying technology of the SensoDetect® BERA test instrument is based on brainstem audiometry and is the result of extensive research at Lund University. Schizophrenia is one of the most devastating mental diseases and ADHD is one of the most common neuropsychiatric disorders. Detection of additional psychiatric conditions using SensoDetect® BERA is under development. SensoDetect® BERA offers great benefits for the patient, and significant economic benefits for health care and society. SensoDetect® BERA also provides an option for objective measurement of medication effects and can also be used for research purposes.